Product Name: ITK (594-613)
Product Number: PE-01BDK85
Size: 1 mg      Price:96.00
5 mg      $US208.00
20 mg      368.00
Peptide Name: ITK (594-613)

Product Use: Services as a blocking peptide for use with the ITK-BCT rabbit polyclonal antibody (Cat. No.: AB-NK274-1) that is also available from Kinexus. The peptide sequence is located in the pre-C-terminus.

Peptide Production Method: Solid-phase peptide synthesis

Peptide Origin: Homo sapiens

Peptide Sequence: CWKERPEDRPAFSRLLRQLA

Peptide Modifications N Terminus: Free amino

Peptide Modifications C Terminus: Amide

Peptide Molecular Mass Calculated: 2470.9 Da

Peptide Purity Percent after Synthesis and Purification: >80

Peptide Appearance: White powder

Peptide Form: Solid

Storage Conditions: -20°C

Related Product 1: ITK pan-specific antibody (Cat. No.: AB-NK274-1)

Scientific Background: ITK is a protein-serine/threonine kinase that is a member of the TK group of protein kinases in the Tec family. This kinase is widely distributed from moderate to high levels in most human tissues with highest expression in bladder, lung, lymph node, spleen, stomach, thymus, tonsils and uterus. Ligation of CD2, TCR or CD28 induces activation and tyrosine phosphorylation of ITK at Y512. ITK is expressed in T-cells and is important for T-cell development and activation through the antigen receptor. ITK require prior activation of Lck, ZAP70 and PI3-kinase for efficient activation. ITK knockout mice show multiple effects on T cell development, cytokine production and T-helper cell differentiation. T cells that lack or express mutant versions of ITK show impaired TCR-induced actin polymerization, cell polarization and regulation of the signalling events involved in cytoskeletal reorganization. ITK has been linked with the development of gastric adenocarcinomas, melanoma (metastatic) and lymphoproliferative syndrome ebv-associated autosomal type 1 (LPSA1).